Hope Or Hype: The Obsession with Medical Advances and the High Cost of False Promises
Annotation Medical science has always promised -- and often delivered -- a longer, better life. But as the pace of science accelerates, do our expectations become unreasonable, fueled by an industry bent on profits and a media desperate for big news?Hope or Hype is a taboo-shattering look at what drives the American obsession with medical "miracles," exposing the equipment manufacturers and pharmaceutical companies; doctors and hospitals too quick to order surgery; the politicians; the press; and our own "technoconsumption" mindset. The authors spread blame for the parade of so-called miracle cures that too often are marginally effective at best -- and sometimes downright dangerous. They examine consumers? eager embrace of medical advances, and present riveting stories of the conscientious doctors and researchers who blew the whistle on ineffective treatments. Finally, they provide sane, practical recommendations for the adoption of new developments. The consequences of questionable practices include costly recalls, billions in wasted money, and the pain and suffering of innumerable patients and their families. In short, they must stop.
Opinião das pessoas - Escrever uma crítica
Não foram encontradas quaisquer críticas nos locais habituais.
Medical Innovations and American Culture
Why More Isnt Always Better
Why Newer Isnt Always Better
Opinion Makers and Regulators
What Will You Swallow?
Making Friends Playing Monopoly and Dirty Tricks
Stacking the Deck?
Medical Devices That Disappoint
Ineffective or Needlessly Extensive Surgery
Weight Loss Technology
For Insurers and Researchers
For All Decision Makers
Outras edições - Ver tudo
Accessed advances advertising agency American approach approval argue artery Association attacks Available become benefit better blood breast cancer called cancer Center clinical common complications consider consumers costs coverage decisions developed devices disease doctors drug companies effective Engl evaluation evidence example expensive experts flecainide funding heart hospital important improve increase industry interest Intern involved JAMA Journal less major makers manufacturers Medicare medicine ments million noted offer operation organizations pain patients percent physicians practice prescribing prescription pressure prevent problems procedure promote published randomized reason received recent reduce reported risk says seems side sometimes story suggested surgeons surgery tests therapy there's things tion treat treatment trials University women York